Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

An Update on the Assessment and Therapeutic Management of Cognitive Decline in Patients with Multiple Sclerosis

Program Overview

This CME program will provide an update on the assessment and therapeutic management of cognitive decline in patients with multiple sclerosis (MS). The expert faculty, Dr. Ann Bass, will first cover multiple sclerosis cognition dysfunction in the modern treatment era, highlighting various measurement tools. Following, recent clinical trial data regarding treatment and prevention of cognitive decline will be ...
View Course
Treatment Strategies for Basal Insulins to Manage Time-in-Range and Glucose Variability to Improve Outcomes in Patients with Diabetes

Program Overview

This CME/CE program will provide clinicians with an update on treatment strategies for basal insulins to manage time-in-range and glucose variability to improve outcomes in patients with diabetes. The expert faculty will review the importance of the role of the diabetes care and education specialist to minimize glucose variability in patients on longer-acting insulins. Next, a clinical review of ...
View Course

Treatment Strategies for Basal Insulins to Manage Time-in-Range and Glucose Variability to Improve Outcomes in Patients with Diabetes

Program Overview

This CME program will highlight treatment strategies for basal insulins to manage time-in-range and glucose variability to improve outcomes in patients with diabetes. The expert faculty, Dr. Neil S. Skolnik, will outline the importance of improving patients’ glucose to time-in-range, minimize glucose variability, and incorporate continuous glucose monitoring in patients with diabetes. Following, Dr. Skolnik will discuss how ...
View Course

Update on the Safety and Efficacy of JAK Inhibitor Therapeutics for the Treatment of Atopic Dermatitis

Program Overview

This CME program will provide clinicians with an update regarding the safety and efficacy of JAK inhibitor therapeutics for the treatment of atopic dermatitis. The expert faculty, led by Dr. Lawrence F. Eichenfield, will first outline current clinical trial data for JAK-1 inhibitor therapeutics in atopic dermatitis (AD), encompassing topics such as difficulties living with AD and the ...
View Course
The Impact of the COVID Pandemic on Continuity of Care and Adherence to DAPT Among Patients with CAD/ACS/PCI

Program Overview

Areas of North America and Western Europe have struggled with repeated waves and emerging variants of SARS CoV-2 infection. Even as some countries and regions strive to return to pre-pandemic behavior, the COVID-19 pandemic continues to exert many deleterious effects on the delivery of continuing healthcare for many vulnerable populations. Those affected include patients who would be expected ...
View Course
Advances in Biomarkers and Anti BCMA Therapeutics to Improve Outcomes in Patients with Relapsed/Refractory Multiple Myeloma

Program Overview

This CME/CE program will highlight recent advances in the treatment and management of patients with relapsed/refractory multiple myeloma (RRMM). The expert faculty, led by C. Ola Landgren, MD, will first discuss best practices for integrating BCMA-targeted therapy into treatment plans for patients with RRMM. Following, emerging therapies in relapsed and remitting multiple myeloma will be reviewed, analyzing both ...
View Course

Upcoming Events

2022 Joint Pre-ECTRIMS Workshop Registration

October 25th, 2022

ASHP Midyear Clinical Meeting and Exhibition

December 4th – 8th, 2022

ESMO Immuno-Oncology Congress 2022

December 7th – 9th, 2022

Advanced Curriculum for Multiple Sclerosis 2023

February 21st – 22nd, 2023